An experimental drug that aims to treat people afflicted with the autoimmune disease lupus showed promising results in its latest round of tests, giving its Rockville-based developer hope that it may have a financial success on its hands.
Human Genome Sciences is set to report the new results on Monday. The drug, called Benlysta, is the first new treatment for lupus in decades to show potential this far into tests with human patients.
Human Genome Sciences is set to report the new results on Monday. The drug, called Benlysta, is the first new treatment for lupus in decades to show potential this far into tests with human patients.
